Cart
sales@molnova.com
XU1
CAS No. 53439-81-9
XU1( —— )
Catalog No. M34473 CAS No. 53439-81-9
XU1（Benzo[c][1,8]naphthyridin-6(5h)-One） is an Aurora protein kinase inhibitor used for the treatment of diseases suitable for inhibition, regulation or modulation of kinase signaling.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 499 | In Stock |
|
| 5MG | 744 | In Stock |
|
| 10MG | 1036 | In Stock |
|
| 25MG | 1518 | In Stock |
|
| 50MG | 2052 | In Stock |
|
| 100MG | 2655 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameXU1
-
NoteResearch use only, not for human use.
-
Brief DescriptionXU1（Benzo[c][1,8]naphthyridin-6(5h)-One） is an Aurora protein kinase inhibitor used for the treatment of diseases suitable for inhibition, regulation or modulation of kinase signaling.
-
DescriptionXU1（Benzo[c][1,8]naphthyridin-6(5h)-One） is an Aurora protein kinase inhibitor used for the treatment of diseases suitable for inhibition, regulation or modulation of kinase signaling.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayCell Cycle/DNA Damage
-
TargetAurora Kinase
-
RecptorAurora Kinase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number53439-81-9
-
Formula Weight196.2
-
Molecular FormulaC12H8N2O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C1C2=C(C=3C(N1)=NC=CC3)C=CC=C2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
CCT 137690
A potent, orally bioavailable Aurora kinases inhibitor with IC50 of 15/25/19 nM for Aurora A/B/C; displays antiproliferative activity in a range of human tumor cell lines, including SW620 colon carcinoma (GI50=0.30 uM) and A2780 ovarian cancer cell line (GI50=0.14 uM).
-
Aurora Kinase Inhibi...
Aurora Kinase Inhibitor II is a cell-permeable anilinoquinazoline that inhibit the activity of Aurora A (IC50 = 0.39 M).
-
BPR1K653
BPR1K653 is a novel potent Aurora kinase inhibitor that inhibits Aurora-A and Aurora-B with IC50 of 24 nM and 45 nM, respectively.
